Last updated: 15 days ago
Moderna, Inc. Financial Report: Mixed Signals as of June 30, 2025
Explore Moderna's Q2 2025 financial report highlighting a net loss of $825M, cash decline, and deferred revenue growth. Investment recommendation: Hold.
Posts With Tag vaccines
Showing 1 - 4 of 4 Posts
Last updated: 4 months ago
Moderna, Inc. Q1 2025 Financial Report: Insights & Future Predictions
Explore Moderna's Q1 2025 financial performance, revealing key sales, losses, and strategic recommendations for investors amid evolving market dynamics.
Last updated: 6 months ago
Moderna, Inc. 2024 Financial Report: Losses and Growth Potential Revealed
Explore Moderna, Inc.'s 2024 financial report highlighting $8.362B revenue, $3.607B loss, and R&D prospects. Investors advised to hold amid market challenges.
Last updated: 8 months ago
Sanofi's 6-K Report: Key Developments & Strategic Moves in December 2024
Explore Sanofi's latest 6-K report detailing board appointments and a Phase 3 vaccine program. Stay updated on key corporate developments and regulatory compliance.